Masako Kuno

787 total citations
25 papers, 614 citations indexed

About

Masako Kuno is a scholar working on Molecular Biology, Physiology and Urology. According to data from OpenAlex, Masako Kuno has authored 25 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Physiology and 5 papers in Urology. Recurrent topics in Masako Kuno's work include Adenosine and Purinergic Signaling (7 papers), Urinary Bladder and Prostate Research (5 papers) and Pelvic floor disorders treatments (2 papers). Masako Kuno is often cited by papers focused on Adenosine and Purinergic Signaling (7 papers), Urinary Bladder and Prostate Research (5 papers) and Pelvic floor disorders treatments (2 papers). Masako Kuno collaborates with scholars based in Japan, United States and United Kingdom. Masako Kuno's co-authors include Takayoshi Kinoshita, Isao Nakanishi, Tadashi Terasaka, Nobuo Seki, Takashi Fujii, Katsuya Nakamura, Masanori Nakakariya, Tsuyoshi Ishii, Masato Yoshikawa and Takatoshi Yogo and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Hepatology.

In The Last Decade

Masako Kuno

25 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masako Kuno Japan 14 291 109 105 101 97 25 614
Pamella J. Ford United States 11 557 1.9× 164 1.5× 29 0.3× 67 0.7× 90 0.9× 19 892
Ashok R. Bapat United States 13 344 1.2× 167 1.5× 19 0.2× 135 1.3× 53 0.5× 20 813
Jadd R. Shelton United States 9 281 1.0× 59 0.5× 50 0.5× 163 1.6× 94 1.0× 13 521
Tokutaro Yasue Japan 17 462 1.6× 44 0.4× 98 0.9× 126 1.2× 55 0.6× 23 813
Mark E. Lesch United States 12 200 0.7× 64 0.6× 48 0.5× 81 0.8× 23 0.2× 17 544
David G. Alberg United States 13 760 2.6× 182 1.7× 30 0.3× 191 1.9× 60 0.6× 18 1.1k
Aaron D. Schuler United States 11 552 1.9× 192 1.8× 114 1.1× 100 1.0× 210 2.2× 17 975
Tomoaki Komai Japan 10 235 0.8× 60 0.6× 16 0.2× 74 0.7× 95 1.0× 14 492
Shih-Fong Chen United States 14 479 1.6× 110 1.0× 88 0.8× 129 1.3× 75 0.8× 22 727
Niek G.J. Leus Netherlands 14 448 1.5× 89 0.8× 17 0.2× 80 0.8× 29 0.3× 21 695

Countries citing papers authored by Masako Kuno

Since Specialization
Citations

This map shows the geographic impact of Masako Kuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Kuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Kuno more than expected).

Fields of papers citing papers by Masako Kuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masako Kuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Kuno. The network helps show where Masako Kuno may publish in the future.

Co-authorship network of co-authors of Masako Kuno

This figure shows the co-authorship network connecting the top 25 collaborators of Masako Kuno. A scholar is included among the top collaborators of Masako Kuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masako Kuno. Masako Kuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamo, Izumi, Hiroshi Nagata, Akio Imanishi, et al.. (2021). Increasing Effects of Selective 5-Hydroxytryptamine Type 2C Receptor Stimulation on Evoked Momentary Urethral Closure in Female Rats and Humans. Journal of Pharmacology and Experimental Therapeutics. 378(2). 60–68. 3 indexed citations
2.
3.
Shibata, Akira, Masako Kuno, Ryutaro Adachi, et al.. (2017). Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy. PLoS ONE. 12(10). e0186587–e0186587. 14 indexed citations
4.
Ishii, Tsuyoshi, Manabu Mochizuki, Masako Kuno, et al.. (2017). CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens. Scientific Reports. 7(1). 13000–13000. 38 indexed citations
5.
Ito, Misato, Shunji Yamazaki, Masako Kuno, et al.. (2016). A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model. Journal of Pharmacological Sciences. 133(1). 25–33. 77 indexed citations
6.
Yukawa, Tomoya, Masami Yamada, Yusuke Ohba, et al.. (2016). Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors – Part 3. Bioorganic & Medicinal Chemistry. 24(16). 3716–3726. 8 indexed citations
7.
Yukawa, Tomoya, Ikuo Fujimori, Masami Yamada, et al.. (2016). Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors—Part 2. Bioorganic & Medicinal Chemistry. 24(14). 3207–3217. 2 indexed citations
8.
Fujimori, Ikuo, Tomoya Yukawa, Masami Yamada, et al.. (2015). Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor. Bioorganic & Medicinal Chemistry. 23(15). 5000–5014. 6 indexed citations
9.
Morita, Yoshiaki, Masako Kuno, Katsuya Nakamura, et al.. (2011). Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor. Biochemical Pharmacology. 82(7). 746–754. 18 indexed citations
10.
Ueno, Hiroyuki, Masako Kuno, Yasushi Shintani, & Izumi Kamo. (2011). Role of vasopressin V1Areceptor in the urethral closure reflex in rats. American Journal of Physiology-Renal Physiology. 300(4). F976–F982. 7 indexed citations
11.
Kuno, Masako, Nobuo Seki, Susumu Tsujimoto, et al.. (2006). Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938. European Journal of Pharmacology. 534(1-3). 241–249. 39 indexed citations
12.
Kinoshita, Takayoshi, Isao Nakanishi, Tadashi Terasaka, et al.. (2005). Structural Basis of Compound Recognition by Adenosine Deaminase. Biochemistry. 44(31). 10562–10569. 36 indexed citations
13.
Terasaka, Tadashi, et al.. (2004). Structure-Based Design, Synthesis, and Structure−Activity Relationship Studies of Novel Non-nucleoside Adenosine Deaminase Inhibitors. Journal of Medicinal Chemistry. 47(15). 3730–3743. 36 indexed citations
14.
Terasaka, Tadashi, Isao Nakanishi, Katsuya Nakamura, et al.. (2003). Structure-Based de novo design of non-nucleoside adenosine deaminase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(6). 1115–1118. 15 indexed citations
15.
Takahashi, Kazumi, Yousuke Furuta, Yoshiko Fukuda, et al.. (2003). In Vitroandin VivoActivities of T-705 and Oseltamivir against Influenza Virus. Antiviral chemistry & chemotherapy. 14(5). 235–241. 71 indexed citations
16.
Kuno, Masako, et al.. (2002). Effects of Differentiation-Inducing Factor-1 (DIF-1) of Dictyostelium discoideum on Bacteria, Fungi, and an Influenza Virus.. The Kitakanto Medical Journal. 52(4). 253–256. 1 indexed citations
17.
18.
Mizuhara, Hidekazu, Masako Kuno, Nobuo Seki, et al.. (1998). Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice. Hepatology. 27(2). 513–519. 48 indexed citations
19.
20.
Kuno, Masako, et al.. (1998). Effect of FK480, a CCK-A Receptor Antagonist, on Spontaneously Developed Chronic Pancreatitis in WBN/ob Rats. Pancreas. 17(3). 295–300. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamella J. Ford Breakdown of academic impact, for papers by Ashok R. Bapat Breakdown of academic impact, for papers by Jadd R. Shelton Breakdown of academic impact, for papers by Tokutaro Yasue Breakdown of academic impact, for papers by Mark E. Lesch Breakdown of academic impact, for papers by David G. Alberg Breakdown of academic impact, for papers by Aaron D. Schuler Breakdown of academic impact, for papers by Tomoaki Komai Breakdown of academic impact, for papers by Shih-Fong Chen Breakdown of academic impact, for papers by Niek G.J. Leus
Rankless by CCL
2026